Sirtex Medical
Germany - BonnBiotechnology
Focus: Sirtex Medical is a Germany-based oncology biotechnology company specializing in cancer treatments, with a focused pipeline in liver cancer, colorectal cancer, and hepatocellular carcinoma. The company operates at a mid-cap scale with minimal public staffing data.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Sirtex Medical
AI assessmentNot HiringNo open roles listed right now. Follow Sirtex Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growing
Growth
Flagship radioembolization therapy in Phase 2/3 trials across multiple cancer indications with expansion into combination regimens.
Pipeline & Clinical Trials
Help build intelligence for Sirtex Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.